The American Society for Radiation Oncology (ASTRO) Gastrointestinal Cancers Resource Panel issued the following statement today regarding the PROSPECT clinical trial for patients with rectal cancer:
Jun 7, 2023
0
29
A widely-circulated clinical trial published earlier this year in the New England Journal of Medicine (NEJM) described a new treatment that eradicated cancer in all 12 of its patients with locally advanced mismatch repair ...
Nov 2, 2022
0
2
March is Colorectal Cancer Awareness Month, which makes this a good time to learn about treating colorectal cancer.
Mar 23, 2022
0
3
Patients with rectal cancer who exercised while undergoing a form of tumor-shrinking radiation therapy in advance of surgery were more likely to have their tumors disappear, according to a University of Alberta study that ...
Oct 26, 2021
0
322
A new and less invasive treatment developed by Cancer Research UK researchers is safer than standard major surgery for early-stage rectal cancer, giving patients a better quality of life with fewer life-altering side effects, ...
Dec 10, 2020
0
3
A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides guidance for physicians who use radiation therapy to treat patients with locally advanced rectal cancer. Recommendations outline indications ...
Oct 21, 2020
0
1
Chemotherapy used to shrink a tumor before surgery, called neoadjuvant chemotherapy, is becoming more common in many cancers, including stage II and III rectal cancer. However, the chemotherapy regimens FOLFOX and CapeOx ...
Jan 30, 2020
0
3
Today's standard procedure to treat rectal cancer includes radical surgery to remove the tumour along with the rectum and its encasing tissue (called mesorectum). After the surgery, the specimen is analysed in the pathology ...
Mar 21, 2019
0
1
While use of the standard therapy leading to the best outcome against locally advanced rectal cancer has increased over the past decade, only half of patients currently receive it, according to a new study. The authors of ...
Apr 13, 2016
0
3
(HealthDay) -- In patients with locally advanced rectal cancer undergoing radical resection, response to neoadjuvant chemoradiotherapy is an early marker that correlates with rates of recurrence-free survival, distant metastases, ...
Apr 10, 2012
0
0
